SCHEMBL1632895

SCHEMBL1632895

CC(C)N1CCN(C(=O)c2ccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc3c2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 10/20 0.53
▸ CCNE1 P24864 5/20 0.53
▸ MTOR P42345 1/20 0.50
▸ SMG1 Q96Q15 1/20 0.50
▸ CA2 P00918 3/20 0.47
▸ CA12 O43570 2/20 0.47
▸ CA1 P00915 2/20 0.47
▸ CA7 P43166 2/20 0.47
▸ CA9 Q16790 2/20 0.47
▸ CDK6 Q00534 2/20 0.46
▸ PIM1 P11309 1/20 0.46
▸ IKBKB O14920 1/20 0.45
▸ CDK7 P50613 4/20 0.44
▸ CCNH P51946 4/20 0.44
▸ CCNA2 P20248 3/20 0.44
▸ MNAT1 P51948 3/20 0.44
▸ CCNK O75909 2/20 0.44
▸ CDK12 Q9NYV4 2/20 0.44
▸ CDK1 P06493 2/20 0.44
▸ DYRK2 Q92630 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1868306 0.93 MTOR (0.50) CDK2CCNE1MTORSMG1CA2
SCHEMBL1632195 0.90 CDK2 (0.56) CDK2CCNE1MTORSMG1CA2
SCHEMBL1633064 0.89 MTOR (0.62) CDK2CCNE1MTORSMG1CA2
SCHEMBL1631321 0.84 CDK2 (0.50) CDK2CCNE1MTORSMG1CA2
SCHEMBL1869926 0.82 MTOR (0.52) CDK2CCNE1MTORSMG1CA2
SCHEMBL3502719 0.81 MTOR (0.62) CDK2CCNE1MTORSMG1CA2
SCHEMBL1633843 0.79 MAPK10 (0.54) CDK2CCNE1MTORSMG1CA2
SCHEMBL1632704 0.79 CDK2 (0.50) CDK2CCNE1CA2CA12CA1
SCHEMBL1633518 0.79 SYK (0.53) CDK2CCNE1CA2CA12CA1
SCHEMBL1570959 0.78 CDK2 (0.50) CDK2CCNE1CA2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback